Bexorg
Medical AI · Drug Discovery
5open roles
2backers · Engine Ventures, Amplify Partners
Growinghiring pace, 59 of 100
36team · US Form 5500 (plan participants) · Dec 2025 · +50% in a year
Overview
Technology About us Careers News and Events Contact us About us ( xo ) From groundbreaking neuroscience begins a transformative future. About ( xo ) Spun out of Yale University, Bexorg is revolutionizing how CNS medicines are discovered and developed.
Funding and backers
Team
36
US Form 5500 (plan participants) · Dec 2025 · +50% in a year
Hiring now
5
+4 posted in 30 days
Backers
2
Engine Ventures, Amplify Partners
Momentum
32/100
hiring for its size
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Team of 36 was 24 · US Form 5500 (plan participants)
Nov 12, 2025
New executive Bexorg Strengthens Leadership Team with Appointment of Sean Murphy, Ph.D., as Chief Technology Officer · YahooFinance
2021
Founded
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Specialist Preclinical Drug Discovery CRO. Leaders in ion channel, cardiac safety and neuroscience screening.
Developing transformative medicines for neurological and mental health disorders.
Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS).
Autobahn aims to improve life health for people affected by CNS disorders by driving the regenerative power of the human body.
NEXI Biotech builds translational in vitro neural models that turn preclinical research into clinical insight — so the next generation of…
Novel therapies for metabolic inflammation and fibrosisThe Elgia team has discovered how metabolic stress drives inflammation and fibrosis…
Jobs
$200k – $250k per year · In office · Full-Time · PhD · New Haven
Python
JAX
Multimodal AI
PyTorch
Self-Supervised Learning
World Models
Machine Learning
DevOps
AWS
Amazon S3
Apply
$200k per year · In office · Full-Time · 10+ years exp · Bachelor's Degree · New Haven
Python
TypeScript
Pydantic
Databases
PostgreSQL
AI/ML
Multimodal AI
Function Calling
AI Agents
AWS Bedrock
LLM
Structured Outputs
Knowledge Graph
LLM Evaluation
DevOps
Terraform
CloudFormation
Prometheus
CI/CD
AWS
Cortex
Amazon S3
IAM
Cybersecurity
ISO 27001
SOC 2
HIPAA
Least Privilege
Life Sciences
GLP
LIMS
Benchling
MedTech
21 CFR Part 11
Apply
In office · Full-Time · 7+ years exp · Associate's Degree · New Haven
qPCR
Cell Culture
GLP
LIMS
Apply
Apply
≈ $36k – $80k per year (Estimated) · In office · Full-Time · Bachelor's Degree · New Haven
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$225k
Typical range
$200k – $250k
Open positions
2
2
Jobs
Principal
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Principal | 2 | $225k | $200k – $250k |
Highest paying role
Principal Scientist — Human Brain Molecular World Model
$250k
Normalized to USD per year
Visa sponsorship
2 ▲ 100%
H-1B filings in 12 months
$133k
Median offered salary
5
Open roles in United States
Who they sponsor
Computer and information research scientists
1
Mechanical engineers
1
In the register as Bexorg, Inc., New Haven, CT
Other sponsors in the same field
Ten63 Therapeutics 4 filings
Prellis Biologics 2 filings
AnaBios 2 filings
Expedition Medicines 1 filings
See 5 open roles Alert me
US Department of Labor · latest filing May 8, 2026 · Visa details by country
Growth
Hiring Momentum
59/100
Growing
Open positions
5
3 opened / 1 closed in 30 days
Median time-to-fill
50 days
faster than 27% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
33% ▲
Backend
17% ▲
Sales
17% ▼
Field & Service
17% ▼
Biotech
17% ▲
Activity Timeline
+3 jobs in a week
Nov 2026
Added qPCR to stack
Nov 2026
Added GLP to stack
Nov 2026
Added Cell Culture to stack
Nov 2026
Added LIMS to stack
Oct 2026
Added ISO 14971 to stack
Oct 2026
Added ISO 13485 to stack
Oct 2026
Added ISO 10993 to stack
Oct 2026
Added IEC 62304 to stack
Oct 2026
Added IEC 60601 to stack
Oct 2026
Added GMP to stack
Oct 2026
Added Linux to stack
Sep 2026
Tech stack
Technologies named in job postings at Bexorg over the last 12 months, by layer, with the share of postings for each.
Technologies in use
46
Postings analysed
5
Stack modernity
72/100AI adopter
Languages
Python
C++
TypeScript
Frameworks & libraries
JAX
PyTorch
Pydantic
Databases
PostgreSQL
Cloud & platforms
AWS
Amazon S3
FreeRTOS
Linux
AI & ML
LLM
Sign in to see how your skills match this stack
Sign In
Full Bexorg tech stack
46 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Engine VenturesVia a fund
Amplify PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
US Startup Bexorg Revives Deceased Brains to Test Neurodegenerative Drugs
The technology is expected to accelerate research on Alzheimer's and Parkinson's drugs
Read more
Report
Bexorg Awarded Grant from The Michael J. Fox Foundation to Identify Translational Biomarkers for TRPML1-Targeted Parkinson's Disease Therapies
Read more
Report
Bexorg Strengthens Leadership Team with Appointment of Sean Murphy, Ph.D., as Chief Technology Officer
Dr. Murphy to lead the continued scale up and expansion of Bexorg's fully integrated AI and whole-human brain platform focused on CNS diseasesNEW HAVEN, Conn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Bexorg, Inc., the first integrated AI and whole-human brain p
Read more
Report
Neuroscience start-up Bexorg nets $42.5 million
The start-up trains AI programs on donated human brains to develop new drug targets
Read more
Report
Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform
Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a techbio company focused on central nervous system/CNS disorders, announced a multi-program research collaboration with Biohaven.
Read more
Report
Bexorg enters research collaboration with Biohaven leveraging its novel AI-driven whole-brain discovery platform to enhance CNS drug development
Bexorg enters research collaboration with Biohaven leveraging its novel AI-driven whole-brain discovery platform to enhance CNS drug development
Read more
Report
Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development
--Bexorg, Inc., a pioneering techbio company working to decode the human brain and advance new therapies for central nervous system disorders, today announced a multi-program research collaboration with Biohaven Ltd. to identify, de-risk, and advance next
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
New Haven
New Haven
United States
HQ
5 open roles 6 posted in 90 days 60% engineering $225k Avg Salary
hires for Science & Research, Backend, Field & Service